DIFELIKEFALIN (Kapruvia®)

Clinical Indication

For moderate to severe pruritus in adults with chronic kidney disease (CKD) having in-centre haemodialysis

Comments

In line with NICE TA890

Date of classification

January 2023

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.